secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2023-10-23T23:59:59+00:00
Accession:  0001013762-23-005859
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics stockholders elect directors and ratify auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- Quang Pham re-elected as Class I director with 10,183,242 votes for, 8,560 withheld; Glynn Wilson with 10,139,612 for, 52,190 withheld.
- WithumSmith+Brown, P.C. ratified as independent auditor for fiscal 2023 with 11,126,433 for, 10,899 against, 192 abstain.
- Quorum achieved with over 34% of 13,022,754 outstanding shares represented at the October 20, 2023 meeting.
- Broker non-votes totaled 945,722 for each director election; none for the auditor ratification (routine matter).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000101376223005859/0001013762-23-005859-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000101376223005859/ea187126-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-005859

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer